Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00401180 · ClinicalTrials.gov registry record · Phase 1
Docetaxel and Temozolomide in Treating Patients With Metastatic Cancer
A Phase 1 study, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- Phase 1
- Development phase
- 25
- Enrollment target
NCT00401180 is a Phase 1 study that has completed, run by The Cleveland Clinic. The registered enrollment target is 25 participants.
The verdict
NCT00401180, a Phase 1 study, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 25 participants
- Enrollment target
Study Summary
RATIONALE: Drugs used in chemotherapy, such as docetaxel and temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells. PURPOSE: This phase I trial is studying the side effects and best dose of docetaxel and temozolomide in treating patients with metastatic cancer.
Interventions
- DRUG docetaxel
- DRUG temozolomide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2002-06 |
| Est. Completion | 2008-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00401180
The ClinicalTrials.gov registry entry for NCT00401180 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which docetaxel is the first listed.
NCT00401180 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00401180 about?
NCT00401180 is a clinical study titled "Docetaxel and Temozolomide in Treating Patients With Metastatic Cancer". RATIONALE: Drugs used in chemotherapy, such as docetaxel and temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells. PURPOSE: This phase I t...
What is the current status of trial NCT00401180?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 25 participants. The study started on 2002-06. Estimated completion is 2008-07.
What interventions are being tested in trial NCT00401180?
The interventions under investigation include: docetaxel (DRUG), temozolomide (DRUG).
Who is sponsoring clinical trial NCT00401180?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.